文献速递睡眠呼吸障碍肺栓塞与肺血管病

阻塞性睡眠呼吸暂停诱导的内皮功能障碍由miR-210介导

Obstructive Sleep Apnea-induced Endothelial Dysfunction Is Mediated by miR-210.
PubMed 文献 · Am J Respir Crit Care Med · 2023-01-01

该研究通过数据挖掘、生物信息学、内皮细胞功能分析、OSA小鼠模型及OSA患者评估,发现间歇低氧诱导内皮细胞miR-210表达上调,其血清浓度在OSA患者中升高且与呼吸暂停低通气指数正相关。机制上间歇低氧诱导SREBP2结合miR-210启动子,抑制铁硫簇组装酶导致线粒体功能障碍,SREBP2抑制剂白桦脂醇可减轻OSA小鼠收缩压升高。

要点

  • OSA患者血清miR-210升高且与呼吸暂停低通气指数正相关
  • 间歇低氧经SREBP2/miR-210轴抑制铁硫簇组装酶致线粒体功能障碍
  • SREBP2抑制剂白桦脂醇减轻OSA小鼠间歇低氧引起的收缩压升高

核心结论

  • SREBP2-miR-210-线粒体功能障碍轴是OSA与内皮细胞功能障碍之间的新机制链接,可能对防治OSA相关心血管后遗症有重要意义。

研究设计与样本

  • 研究结合数据挖掘、生物信息学分析、内皮细胞功能分析、OSA小鼠模型及OSA患者评估。
  • 利用两个独立队列的OSA患者血清检测miR-210浓度。

主要发现

  • 间歇低氧对内皮细胞miR-210的诱导作用最强。
  • 两个独立队列中OSA患者血清miR-210浓度均高于对照,且与呼吸暂停低通气指数正相关。
  • 转染miR-210或经OSA血清处理的内皮细胞中,一组共同改变的基因主要涉及线粒体相关通路。
  • 转染miR-210或经OSA血清处理的内皮细胞显示氧消耗速率、线粒体膜电位和DNA丰度降低。
  • 间歇低氧诱导SREBP2结合miR-210启动子区,进而抑制铁硫簇组装酶导致线粒体功能障碍。

临床怎么用

  • miR-210可能作为OSA相关内皮功能障碍的血清标志物,并与呼吸暂停低通气指数相关。
  • SREBP2抑制剂白桦脂醇在OSA小鼠模型中减轻间歇低氧引起的收缩压升高,提示潜在治疗方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Obstructive sleep apnea (OSA)-induced endothelial cell (EC) dysfunction contributes to OSA-related cardiovascular sequelae. The mechanistic basis of endothelial impairment by OSA is unclear. Objectives: The goals of this study were to identify the mechanism of OSA-induced EC dysfunction and explore the potential therapies for OSA-accelerated cardiovascular disease. Methods: The experimental methods include data mining, bioinformatics, EC functional analyses, OSA mouse models, and assessment of OSA human subjects. Measurements and Main Results: Using mined microRNA sequencing data, we found that microRNA 210 (miR-210) conferred the greatest induction by intermittent hypoxia in ECs. Consistently, the serum concentration of miR-210 was higher in individuals with OSA from two independent cohorts. Importantly, miR-210 concentration was positively correlated with the apnea-hypopnea index. RNA sequencing data collected from ECs transfected with miR-210 or treated with OSA serum showed a set of genes commonly altered by miR-210 and OSA serum, which are largely involved in mitochondrion-related pathways. ECs transfected with miR-210 or treated with OSA serum showed reduced [Formula: see text]o2 rate, mitochondrial membrane potential, and DNA abundance. Mechanistically, intermittent hypoxia-induced SREBP2 (sterol regulatory element-binding protein 2) bound to the promoter region of miR-210, which in turn inhibited the iron-sulfur cluster assembly enzyme and led to mitochondrial dysfunction. Moreover, the SREBP2 inhibitor betulin alleviated intermittent hypoxia-increased systolic blood pressure in the OSA mouse model. Conclusions: These results identify an axis involving SREBP2, miR-210, and mitochondrial dysfunction, representing a new mechanistic link between OSA and EC dysfunction that may have important implications for treating and preventing OSA-related cardiovascular sequelae.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Shang F, Wang SC, Gongol B, et al. Obstructive Sleep Apnea-induced Endothelial Dysfunction Is Mediated by miR-210. Am J Respir Crit Care Med. 2023. PMID: 36191258. doi:10.1164/rccm.202202-0394OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。